Heal
-
DATABASE (312)
-
ARTICLES (3)
Ibersol is a Portuguese restaurant sector investor established in 1994. It holds the franchises of several of Spain and Portugal's top-selling fast-food chains including Burger King in both nations, Pans & Company in Spain and KFC in Portugal and Angola.To date, it has invested in one startup, the Portuguese healthy food service EatTasty, with undisclosed investment in the company's seed stage, phase one, that raised €1.1m. It also acquired one food sector entity, the Spanish restaurant group, Eat Out Group, for an undisclosed sum in 2016.
Ibersol is a Portuguese restaurant sector investor established in 1994. It holds the franchises of several of Spain and Portugal's top-selling fast-food chains including Burger King in both nations, Pans & Company in Spain and KFC in Portugal and Angola.To date, it has invested in one startup, the Portuguese healthy food service EatTasty, with undisclosed investment in the company's seed stage, phase one, that raised €1.1m. It also acquired one food sector entity, the Spanish restaurant group, Eat Out Group, for an undisclosed sum in 2016.
Established in 2015, Olisipo Way is a Portuguese investor that funds early-stage investment in Portuguese tech and non-tech startups with a potential for international expansion acros all market verticals. It currently has 26 startups in its portfolio and recent investments include in the €125,000 pre-seed and €1.1m first phase seed round of healthy food service EatTasty. It has also invested in the €350,000 pre-seed round of revenue management for traveltech Climber and in the US$725,000 pre-seed round of adtech advertio.
Established in 2015, Olisipo Way is a Portuguese investor that funds early-stage investment in Portuguese tech and non-tech startups with a potential for international expansion acros all market verticals. It currently has 26 startups in its portfolio and recent investments include in the €125,000 pre-seed and €1.1m first phase seed round of healthy food service EatTasty. It has also invested in the €350,000 pre-seed round of revenue management for traveltech Climber and in the US$725,000 pre-seed round of adtech advertio.
Based in Shanghai, Sharewin Investment was founded in 2005. In 2010, the company changed its focus from PE to VC. It invests mainly in the healthcare, TMT, new material, advanced manufacturing, arts and entertainment and consumer products sectors.
Based in Shanghai, Sharewin Investment was founded in 2005. In 2010, the company changed its focus from PE to VC. It invests mainly in the healthcare, TMT, new material, advanced manufacturing, arts and entertainment and consumer products sectors.
CICFH was co-founded in 2013 by China Investment Securities, ZhongCai Financial Holding Investment and other companies. Based in Tianjin, the VC manages multiple funds worth over RMB 80bn in total.CICFH focuses on M&A in emerging industries and mainly invests in sectors of media, arts, entertainment, healthcare, fintech and environmental technology through multiple funds established with other enterprises. It has also set up multiple FoFs, partnering with provincial governments to spur the development of certain industries.
CICFH was co-founded in 2013 by China Investment Securities, ZhongCai Financial Holding Investment and other companies. Based in Tianjin, the VC manages multiple funds worth over RMB 80bn in total.CICFH focuses on M&A in emerging industries and mainly invests in sectors of media, arts, entertainment, healthcare, fintech and environmental technology through multiple funds established with other enterprises. It has also set up multiple FoFs, partnering with provincial governments to spur the development of certain industries.
Shangshi Capital was founded and headquartered in Beijing in 2014. It has branch offices in Shenzhen and San Francisco. The firm manages two US dollar funds and three RMB funds, totaling over RMB 1.5bn. It has invested in over 60 startups at home and abroad, mainly in digital healthcare, consumer goods, IoT and enterprise tech.
Shangshi Capital was founded and headquartered in Beijing in 2014. It has branch offices in Shenzhen and San Francisco. The firm manages two US dollar funds and three RMB funds, totaling over RMB 1.5bn. It has invested in over 60 startups at home and abroad, mainly in digital healthcare, consumer goods, IoT and enterprise tech.
Asabys Partners is a VC firm based in Barcelona and invests mainly in the healthtech and biopharma industries. Backed by Sabadell Bank, the VC now has offices in Spain, UK, Switzerland and Israel. Asabys Partners aims to accelerate technology breakthroughs in the fields of science and medicine by supporting a network of industry experts and talent.Asabys started operations in 2019 and is currently fundraising its first fund, Sabadell Asabys Health Innovation Investments, with a target size of €70m and Banc Sabadell as anchor investor. Main areas of investment include Biopharma, MedTech and Digital Therapeutics.
Asabys Partners is a VC firm based in Barcelona and invests mainly in the healthtech and biopharma industries. Backed by Sabadell Bank, the VC now has offices in Spain, UK, Switzerland and Israel. Asabys Partners aims to accelerate technology breakthroughs in the fields of science and medicine by supporting a network of industry experts and talent.Asabys started operations in 2019 and is currently fundraising its first fund, Sabadell Asabys Health Innovation Investments, with a target size of €70m and Banc Sabadell as anchor investor. Main areas of investment include Biopharma, MedTech and Digital Therapeutics.
Carlos Gallardo is an industrial engineer with an MBA from Stanford University. He spent most of his career at the pharmaceutical company Almirall and was promoted through the ranks rapidly holding multiple C-level roles. He became the MD for UK and Ireland for over five years and joined Almirall’s board of directors in 2014.In 2015, he founded CG Health Ventures, a VC firm investing in early-stage digital health companies worldwide. He’s also an active angel investor and advisor for startups developing frontier technologies in the healthcare sector.
Carlos Gallardo is an industrial engineer with an MBA from Stanford University. He spent most of his career at the pharmaceutical company Almirall and was promoted through the ranks rapidly holding multiple C-level roles. He became the MD for UK and Ireland for over five years and joined Almirall’s board of directors in 2014.In 2015, he founded CG Health Ventures, a VC firm investing in early-stage digital health companies worldwide. He’s also an active angel investor and advisor for startups developing frontier technologies in the healthcare sector.
Endeavor Catalyst is part of the global investment company Endeavor. Launched in 2012 and based in New York, it supports the equity funding efforts of Endeavour entrepreneurs with third party investors. Its portfolio investments had a total capital value of over US$100 million and it specializes in mid-stage investments across sectors and different countries, with significant investment in transportation startups to date. In 2020, it participated in the second €12m part of the €23m Series A round of EV charging hardware startup, Wallbox, with an undisclosed investment. Other recent investments in 2020 include in the US$40m Series D round of Egyptian healthtech Vezeeta and in the undisclosed seed round of Turkish fintech Figopara.
Endeavor Catalyst is part of the global investment company Endeavor. Launched in 2012 and based in New York, it supports the equity funding efforts of Endeavour entrepreneurs with third party investors. Its portfolio investments had a total capital value of over US$100 million and it specializes in mid-stage investments across sectors and different countries, with significant investment in transportation startups to date. In 2020, it participated in the second €12m part of the €23m Series A round of EV charging hardware startup, Wallbox, with an undisclosed investment. Other recent investments in 2020 include in the US$40m Series D round of Egyptian healthtech Vezeeta and in the undisclosed seed round of Turkish fintech Figopara.
B Capital Group is best known as the venture capital firm co-founded by Eduardo Saverin, co-founder of Facebook. Its investment thesis focuses on connecting highly innovative and agile startups with major corporates that are in need of innovation and have the resources to innovate. As such, B Capital has a special interest in B2B companies that have great potential to disrupt critical industries. This includes startups that are disrupting healthcare and biotechnology, as well as finance and insurance. B Capital has also supported some notable B2C companies, including coffee chain Kopi Kenangan and used car marketplace Carro.
B Capital Group is best known as the venture capital firm co-founded by Eduardo Saverin, co-founder of Facebook. Its investment thesis focuses on connecting highly innovative and agile startups with major corporates that are in need of innovation and have the resources to innovate. As such, B Capital has a special interest in B2B companies that have great potential to disrupt critical industries. This includes startups that are disrupting healthcare and biotechnology, as well as finance and insurance. B Capital has also supported some notable B2C companies, including coffee chain Kopi Kenangan and used car marketplace Carro.
Jonathan Neman is a co-founder and co-CEO of USA healthy-eating restaurant franchise Sweetgreen. As co-CEO, he has managed the salad chain since opening its first outlet in 2007, raising more than $470m in VC funding in the process. Neman is also an investor in various F&B startups, such as frozen food maker EatPops and Indonesian coffee chain Kopi Kenangan.
Jonathan Neman is a co-founder and co-CEO of USA healthy-eating restaurant franchise Sweetgreen. As co-CEO, he has managed the salad chain since opening its first outlet in 2007, raising more than $470m in VC funding in the process. Neman is also an investor in various F&B startups, such as frozen food maker EatPops and Indonesian coffee chain Kopi Kenangan.
Ship2B is an accelerator and investor for social impact startups and spin-offs. It acts principally in three sectors: health tech, social tech for vulnerable groups and climate technology. It also fosters networking alliances between startups and large companies, and has a network of high-level mentors available to assist startups.To date, Ship2B has invested €40m in 146 startups and spin-offs.
Ship2B is an accelerator and investor for social impact startups and spin-offs. It acts principally in three sectors: health tech, social tech for vulnerable groups and climate technology. It also fosters networking alliances between startups and large companies, and has a network of high-level mentors available to assist startups.To date, Ship2B has invested €40m in 146 startups and spin-offs.
Picart Petcare is the family business of Albert Icart Martori, co-founder of Kibus Petcare. It has been in operation since 1953 and is based in Barcelona. Not usually an investor in tech or startups, it has invested solely in healthy pet food preparation hardware startup Kibus with a pre-seed investment of €120,000 in 1Q 2019. Picart distributes pet food and animal feed in more than 25 European and Middle Eastern markets and is set to be a key distributor of Kibus' hardware.
Picart Petcare is the family business of Albert Icart Martori, co-founder of Kibus Petcare. It has been in operation since 1953 and is based in Barcelona. Not usually an investor in tech or startups, it has invested solely in healthy pet food preparation hardware startup Kibus with a pre-seed investment of €120,000 in 1Q 2019. Picart distributes pet food and animal feed in more than 25 European and Middle Eastern markets and is set to be a key distributor of Kibus' hardware.
Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas.
Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas.
Baiyang Capital was founded in 2014 by BAHEAL Pharmaceutical Holdings Limited and several senior professionals in the pharmaceutical and healthcare fields. The investment management company operates multiple funds, targeting pharmaceutical and healthcare businesses.
Baiyang Capital was founded in 2014 by BAHEAL Pharmaceutical Holdings Limited and several senior professionals in the pharmaceutical and healthcare fields. The investment management company operates multiple funds, targeting pharmaceutical and healthcare businesses.
Headquartered in Shanghai, FC Capital was founded in 2017 to focus on investments in China and the US. The VC mainly invests in medtech sectors like biotechnology, medical devices, medical services and health-related consumer products.
Headquartered in Shanghai, FC Capital was founded in 2017 to focus on investments in China and the US. The VC mainly invests in medtech sectors like biotechnology, medical devices, medical services and health-related consumer products.
Neurafarm: Putting an AI plant doctor in farmers' hands
This startup is riding on Indonesia’s urban farming trend with its planting kit and an AI-powered app that identifies plant diseases from photos of unhealthy leaves
HypeLabs wins bumper US$3m seed funding to democratize connectivity
HypeLab's P2P mesh networking technology enables everyone to communicate within their own networks without needing internet, in cities, remote villages and even in disaster zones
Knokcare: Telemedicine app connects you to doctors in 30 minutes
Seeking funding of over €1m, Portugal’s digital healthcare pioneer is expanding its SaaS to tap new markets in Europe, Africa and Latin America
Sorry, we couldn’t find any matches for “Heal”.
POPULAR DATABASE
